Trends in treatment referral and completion

In 2024–25:

  • For all treatment episodes (244,411), the most common referral into treatment was self or family (37%, 91,419 episodes) followed by referral by health services (33%, 80,384 episodes):
    • This referral pattern into treatment was consistent for all treatment types except for information and education (57%), assessment only (33%) and other treatment types (49%) where health services was the most common referrals.
  • Referrals into treatment for a client’s own alcohol or drug use (214,662 episodes) and someone else’s alcohol or drug use (29,749 episodes) were similar:
    • Self or family (37%) was most common for a client’s own alcohol or drug use, followed by health service (32%).
    • Self or family (42%) was the most common referral for clients who received treatment for someone else’s alcohol or drug use, followed by health service (36%).
  • Diversion (8.0%, 17,184 episodes) referrals into treatment were most common for a client’s own alcohol or drug use.
    • Treatment episodes referred via diversion were most common for ecstasy (25%) and cocaine (15%) (tables Trt.10, Trt.11, Drg.13).

Between 2015–16 and 2024–25:

  • Diversion referrals fell from 17% (34,620) in 2015–16 to 7.2% (17,696) in 2024–25.
  • Where a referral came from an ‘other’ referral source, treatment episodes rose from 7.8% (16,096) in 2015–16, peaking at 17% (40,474) in 2019–20, before falling to 13% (31,552) in 2024–25.
    • Other source of referral includes persons referred through community services, government departments, remand or prison, education (through teachers and schools).
  • Self or family referrals remained stable (37% or 76,725 in 2015–16 and 37% or 91,419 in 2024–25).
  • Health service referrals rose from 28% (56,962) to 33% (80,384) (tables Trt.10, Trt.11).
  • Referrals into treatment varied according to clients’ principal drug of concern. Among episodes (214,662) for a client’s own alcohol or drug use (Figure 1, Table Drg.13):
    • Where alcohol was the principal drug of concern, referrals from self or family (41%, 26,224 in 2015–16 and 41%, 35,701 in 2024–25) or a health service (36%, 22,987 in 2015–16 and 38%, 33,357 in 2024–25) remained stable.
    • Where methamphetamines were the principal drug of concern:
      • Referrals rose for health services (22%, 4,689 in 2015–16 to 28%, 14,235 in 2024–25) and corrections (9.8%, 2,074 in 2015–16 to 16%, 8,299 in 2024–25).
      • Self or family referrals proportionally fell, from 44% (9,242) in 2015–16 to 36% (18,271) in 2024–25.
    • Where cannabis was the principal drug of concern:
      • Diversion referrals fell, from 36% (16,152) in 2015–16 to 12% (3,586) in 2024–25.
      • The proportion of referrals rose for self or family (from 28%, 12,419 in 2015–16 to 31%, 9,527 in 2024–25) and health services (from 23%, 10,476 in 2025–16 to 31%, 9,442 in 2024–25).

Figure 1: Treatment episodes for own drug use, by principal drug of concern and referral source, 2015–16 to 2024–25

Line graph shows the proportion of episodes by source of referral among treatment episodes with alcohol as the principal drug of concern between 2015–16 and 2024–25. Data is filtered by different principal drugs of concern.

Line graph shows the proportion of episodes by source of referral among treatment episodes with alcohol as the principal drug of concern between 2015–16 and 2024–25. Data is filtered by different principal drugs of concern.